MedPath

Comparison of using corticosteroids metered dose inhaler with or without spacer

Not Applicable
Conditions
Asthma.
Asthma
Registration Number
IRCT20230731058982N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
114
Inclusion Criteria

Adults over 18 to 65 years old with uncontrolled or poorly controlled asthma (ACT score < 20)
Using corticosteroid inhalers in the form of MDI (metered dose inhaler) for at least three months before starting the study and being adherent to treatments
Not Having a critical error when using inhalation spray

Exclusion Criteria

Suffering from any tremors, Parkinson's, or using medications that cause tremors continuously
Neuro-cognitive problems that lead to incorrect use of the inhaler by the patient.
Not consented to include in the trial

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Asthma Control Test (ACT). Timepoint: Six weeks. Method of measurement: Asthma Control Test questionnaire.;Spirometry indexes including FEV1? FVC? FEV1/FVC. Timepoint: before intervention and 6 weeks after intervention. Method of measurement: Spirometry.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath